Adaptive Immune Response Impairs the Efficacy of Autologous Transplantation of Engineered Stem Cells in Dystrophic Dogs-Reference-Cited by-同舟云学术

Adaptive Immune Response Impairs the Efficacy of Autologous Transplantation of Engineered Stem Cells in Dystrophic Dogs

Published:2016-11 Issue:11 Volume:24 Page:1949-1964
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Sitzia Clementina,Farini Andrea,Jardim Luciana,Razini Paola,Belicchi Marzia,Cassinelli Letizia,Villa Chiara,Erratico Silvia,Parolini Daniele,Bella Pamela,da Silva Bizario Joao Carlos,Garcia Luis,Dias-Baruffi Marcelo,Meregalli Mirella,Torrente Yvan

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference50 articles.

1. Dystrophin: the protein product of the Duchenne muscular dystrophy locus;Hoffman;Cell,1987

2. A quantitative study of myonuclear and satellite cell nuclear size in Duchenne's muscular dystrophy, polymyositis and normal human skeletal muscle;Watkins;Anat Rec,1988

3. Muscular dystrophy into the new millennium;Emery;Neuromuscul Disord,2002

4. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy;Péault;Mol Ther,2007

5. New therapies for muscular dystrophy: cautious optimism;Cossu;Trends Mol Med,2004

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric Cell Therapies as a Novel Approach for Duchenne Muscular Dystrophy (DMD) and Muscle Regeneration;Biomolecules;2024-05-13

2. Amelioration of Morphological Pathology in Cardiac, Respiratory, and Skeletal Muscles Following Intraosseous Administration of Human Dystrophin Expressing Chimeric (DEC) Cells in Duchenne Muscular Dystrophy Model;Biomedicines;2024-03-06

3. Enhanced Diaphragm Muscle Function upon Satellite Cell Transplantation in Dystrophic Mice;International Journal of Molecular Sciences;2024-02-21

4. Safety and Efficacy of DT-DEC01 Therapy in Duchenne Muscular Dystrophy Patients: A 12 - Month Follow-Up Study After Systemic Intraosseous Administration;Stem Cell Reviews and Reports;2023-09-14

5. Duchenne muscular dystrophy disease severity impacts skeletal muscle progenitor cells systemic delivery;Frontiers in Physiology;2023-05-09